  
 
Jointly Provided by: Penn Medicine and ViralEd, Inc.
 
 
 
 
 
 
About the Program
 Program Overview
The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to present this ground-breaking CME activity. Mirroring academic grand rounds programs, these CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania is live webcast every Thursday at 12:00pm Eastern Time starting in October through June. All webcasts will be available for on-demand viewing immediately following the live broadcast.  CME credit will be available for 24 hours following the start of each webcast.
 
Presentations cover the most important and current topics in HIV/AIDS and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing HIV clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These weekly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.
 
Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/hivgrandrounds for easy access. 
 
Target Audience
 
This program has been designed for Family
Medicine, Psychiatry, Public Health and General Preventive Medicine, Internal Medicine, Internal Medicine - Infectious Diseases, All Specialties.
 
Commercial Support Acknowledgement
HIV Grand Rounds is supported by independent educational grants from  ViiV Healthcare, Merck & Co. and Gilead Sciences, Inc.
 
Learning Objectives
After completing this activity, participants should be better able to: 
 
	- Describe how to apply in clinical practice approaches for preventing HIV infection and getting newly diagnosed patients rapidly into care
	
 
	- Describe how to manage various patient populations, such as the aging 
	patient with HIV infection, including issues associated with 
	cardiovascular and bone disease, PWIDs and underserved populations
 
	- Discuss the basic science concepts involved with HIV and be able to 
	apply those concepts to HIV therapeutics, epidemiology, and other issues involved in 
	HIV patient care and HIV prevention
 
	- Discuss how to individualize ARV therapy for the treatment-naïve and treatment-experienced patients to support adherence and patient satisfaction 
 
 
Current Session Learning Objectives
After completing this activity, participants should be better able to: 
 
	- Describe how socio-behavioral research can inform the development, uptake, and effectiveness of emerging HIV and HBV therapeutics.
 
	- Identify and discuss strategies to integrate socio-behavioral evidence into translational and clinical research to strengthen the real-world impact of HIV and HBV therapies.
 
 
Course Directors
	
		
			| 
			 
			
			 
			
			Ian Frank, MD 
			Professor of Medicine 
			Director, Clinical Therapeutics Program 
			Penn Center for AIDS Research 
			Perelman School of Medicine at the 
			University of Pennsylvania 
			Philadelphia, Pennsylvania
			 
			
			Katherine Bar, MD 
			Associate Professor  
			Department of Medicine  
			Perelman School of Medicine at the 
			University of Pennsylvania 
			Philadelphia, Pennsylvania
			 
			
			Florence Momplaisir, MD, MSHP, FACP 
			Assistant Professor of Medicine 
			Vice Chair for Diversity, Equity and Inclusion (DEI) in Infectious Diseases 
			Perelman School of Medicine at the University of Pennsylvania 
			Philadelphia, Pennsylvania
			 
			 | 
		 
	
 
Next Session and Participation Information
	- Delivered via webinar directly to you  and/or your clinic
 
	- You, or your clinic's coordinator, will receive a weekly email with topic, speaker and webinar link
 
	- Sessions can be viewed in a large conference room or auditorium for large group viewing and participation, or directly on your personal computer, tablet or smart device
 
 
If CME credit is desired for any of the live sessions, proceed to https://upenn.cloud-cme.com to create your personal CME account. After your account is established this one time, following each session simply text the session code listed in the presentation slides to receive your CME credit. 
 
 
 
Live Session Topics and Speakers
	
		
			| 
			 
			January 30, 2025
			 
			
			HIV Prevention for Cisgender Women: Improving the PrEP Care Continuum
			 
			
			Jessica Ridgway, MD
			 
			
			Click HERE to View On-Demand
			 
			 
			
			February 6, 2025
			 
			
			The Top Ten Publications in HIV Medicine in 2024
			 
			
			Ian Frank, MD
			 
			
			Click HERE to View On-Demand
			 
			 
			
			February 13, 2025
			 
			
			Stigma & Syndemics: a challenge in HIV and viral hepatitis elimination research
			 
			
			M. Elle Saine, MD, PhD, MA
			 
			
			Click HERE to View On-Demand
			 
			 
			
			February 20, 2025
			 
			
			Sex differences in excess weight gain among people initiating or switching to integrase strand transfer inhibitors (INSTIs) for HIV treatment
			 
			
			Florence Momplaisir, MD, MSHP, FACP
			 
			
			Click HERE to View On-Demand
			 
			 
			
			February 27, 2025
			 
			
			Decoding the HIV Reservoir
			 
			
			Laura A. Vella, MD, PhD
			 
			
			Click HERE to View On-Demand
			 
			 
			
			March 6, 2025
			 
			
			Current Approaches in the Development of New Drugs and Regimens for Tuberculosis
			 
			
			David L. Holtzman, MD
			 
			
			Click HERE to View On-Demand
			 
			 
			
			March 20, 2025
			 
			
			Highlights from CROI 2025, Part I: ART and Comorbidities
			 
			
			Renslow Sherer, MD
			 
			
			Click HERE to View On-Demand
			 
			 
			
			March 27, 2025
			 
			
			Using implementation science to enhance sexual wellness among people who receive care at safety-net clinics in the Southern U.S.
			 
			
			Jessica Sales, PhD, MA
			 
			
			Click HERE to View On-Demand
			 
			 
			
			 
			 
			
			April 3, 2025
			 
			
			HIV Care Challenges For Pregnant and Breastfeeding Women in South Africa and a Discussion about Supporting Safe Feeding Options
			 
			
			Natasha Davies, MBChB, MPH, HIV Man Dip (SA)
			 
			
			Click HERE to View On-Demand
			 
			 
			
			 
			 
			
			April 10, 2025
			 
			
			Highlights from CROI 2025, Part II:  Epidemiology, Prevention and Coinfections
			 
			
			Renslow Sherer, MD
			 
			
			Click HERE to View On-Demand
			 
			 
			
			April 24, 2025
			 
			
			Leveraging Implementation Science to Close Equity Gaps in PrEP Service Delivery
			 
			
			Latesha Elopre, MD, MSPH
			 
			
			Click HERE to View On-Demand
			 
			 
			
			May 1, 2025
			 
			
			Biopsychosocial Phenotypes and CSF CSF-plasma compartmentalization in People with HIV (Insights from the CHARTER Cohort)
			 
			
			Ronald Joseph Ellis, MD, PhD
			 
			
			Click HERE to View On-Demand
			 
			 
			
			May 8, 2025
			 
			
			HIV and Viral Hepatitis: an update
			 
			
			Jürgen Rockstroh, MD
			 
			
			Click HERE to View On-Demand
			 
			 
			
			May 15, 2025
			 
			
			Real Cases from the University of Pennsylvania
			 
			
			Mary Ferranti, MD, Kurt Koehler, MD , Elle Saine, MD and Jung Seo, MD
			 
			
			Click HERE to View On-Demand
			 
			 
			
			May 22, 2025
			 
			
			Anal Cancer Prevention & High-Resolution Anoscopy: A Primer for the Infectious Diseases Physician
			 
			
			Cristina Brickman, MD
			 
			
			Click HERE to View On-Demand
			 
			 
			
			May 29, 2025
			 
			
			Structural Violence, Relational Repair: Reimagining Harm Reduction in Healthcare Settings
			 
			
			Mary Hawk, DrPH, LSW
			 
			
			Click HERE to View On-Demand
			 
			 
			
			June 5, 2025
			 
			
			Challenges When Managing Syphilis in Persons with HIV
			 
			
			Khalil Ghanem, MD, PhD
			 
			
			Click HERE to View On-Demand
			 
			 
			
			June 12, 2025
			 
			
			Medical-Legal Partnerships: A Promising Approach for Engaging Vulnerable Populations in the HIV Prevention and Care Continua
			 
			
			Omar Martinez, JD, MPH, MS
			 
			
			Click HERE to View On-Demand
			 
			 
			
			June 19, 2025
			 
			
			Function and Frailty in HIV:  Why we should care and what we can do?
			 
			
			Kristine Erlandson, MD
			 
			
			Click HERE to View On-Demand
			 
			 
			
			June 26, 2025
			 
			
			The Fight to End HIV/AIDS Circa 2025: Navigating Scientific Opportunity and Political Chaos at the Same Time
			 
			
			Mitchell Warren
			 
			
			Click HERE to View On-Demand
			 
			 
			
			September 11, 2025
			 
			
			Driving Systems Change in Academic–Practice Partnerships through Implementation Science: Insights from the NIH Centers for AIDS Research 
			 
			
			Ann Namkung, DrPH, MPH
			 
			
			Click HERE to View On-Demand
			 
			 
			
			September 25, 2025
			 
			
			Highlights from the 13th IAS Conference on HIV Science (IAS 2025)
			 
			
			Ian Frank, MD
			 
			
			Click HERE to View On-Demand
			 
			 
			
			October 9, 2025
			 
			
			Mpox: Where Are We Now?
			 
			
			Jason Zucker, MD
			 
			
			Click HERE to View On-Demand
			 
			 
			
			October 23, 2025
			 
			
			Passive immunity to HIV with monoclonal antibodies – a new class of HIV PrEP
			 
			
			Huub Gelderblom, MD, MSc, PhD, MPH
			 
			
			Click HERE to View On-Demand
			 
			 
			
			October 30, 2025
			 
			
			Broadly Neutralizing Antibodies in HIV Treatment and Cure: From Infusion to Gene Delivery to Vaccines
			 
			
			Pablo Tebas, MD
			 
			
			Click HERE to View On-Demand
			 
			 
			
			November 6, 2025
			 
			
			Integrating Socio-Behavioral Research to Shape the Future of HIV and HBV Therapeutics
			 
			
			Karine Dubé, DrPH, MPhil
			 
			
			Click HERE to Register
			 
			 
			
			November 13, 2025
			 
			
			Topic TBD
			 
			
			Denis Nash, PhD, MPH
			 
			
			Click HERE to Register
			 
			 
			
			November 20, 2025
			 
			
			Real Cases from the University of Pennsylvania - Infections in Injection Drug Users
			 
			
			Wei-Teng Yang, MD, MPH
			 
			
			Click HERE to Register
			 
			 
			
			December 4, 2025
			 
			
			Topic: TBA
			 
			
			Presenter: TBA
			 
			
			Click HERE to Register
			 
			 
			
			December 11, 2025
			 
			
			Highlights from IDWeek 2025 and EACS 2025
			 
			
			Graeme Moyle, MD
			 
			
			Click HERE to Register
			 
			 
			
			December 18, 2025
			 
			
			Analyzing the Scale-Up of PrEP:  Leveraging Prescription Datasets to Develop New Insights
			 
			
			Aaron Siegler, PhD, MHS
			 
			
			Click HERE to Register
			 
			 
			
			 
			 
			TO VIEW PREVIOUS HIV GRAND ROUNDS PLEASE SEE BELOW: 
			 | 
		 
	
 
 
 
 
Hardware/Software Notice
You will need Internet to participate in this activity.
 
Accreditation Statement
 
In support of improving patient care, this activity has been planned and implemented by Penn Medicine and ViralEd. Penn
Medicine is jointly accredited by the Accreditation Council for Continuing
Medical Education (ACCME), the Accreditation Council for Pharmacy Education
(ACPE), and the American Nurses Credentialing Center (ANCC), to provide
continuing education for the healthcare team.
 
Designation of Credit
Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians
should claim only the credit commensurate with the extent of their
participation in the activity.
 
Nurses/Pharmacists:
This activity is not approved
for nursing or pharmacy contact hours
 
PAs: AAPA accepts certificates of participation for educational
activities certified for AMA PRA Category 1 Credit™ from organizations
accredited by ACCME or a recognized state medical society. PAs may receive a
maximum of 1.00 Category 1 credits for completing
this activity. 
 
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at Penn Medicine Office of
Continuing Medical and Interprofessional Education for individuals who are in a
position to control the content of an educational activity to disclose to the
learners all relevant financial relationships that they have with any commercial
interest that provide products or services that may be relevant to the content
of this continuing education activity. 
For this purpose, we consider relationships of the person involved to
include financial relationships of a spouse or partner.
 
The
intent of this policy is to ensure that Penn CME/CE certified activities
promote quality and safety, are effective in improving medical practice, are based
on valid content, and are independent of control from commercial interests and
free of commercial bias. Peer review of all content was conducted for all
faculty presentations whose disclosure information was found to contain
relationships that created a conflict of interest relevant to the topic of
their presentation. In addition, all faculty were instructed to provide
balanced, scientifically rigorous and evidence-based presentations. 
 
The staff in the Office of Continuing Medical and Interprofessional Education (CME and
IPCE)  have disclosed that they have no relevant financial
relationships with any commercial interests related to the content of 
this
educational activity. Any peer reviewer with a potential conflict of 
interest will recuse themselves from the peer review process.
 
The following faculty or planning committee members have
disclosed that they have no relevant financial relationships with any
commercial interests related to the content of this educational activity:
 
	
		
			| 
			 
			Florence Momplaisir, MD (Program Co-Director)
			 
			
			
			Planning Committee Members:
			
			 
			
				- ViralEd, Inc.: Brian Boyle, MD; Rick Gordon
 
			 
			
			
			
			
			
			
			
			
			
			
			 
			
			 | 
		 
	
 
The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:
 
 
	
		
			| 
			 
			Ian Frank, MD (Program Co-director)
			 
			
				- Membership on Advisory Committees or Review Panels, Board Membership, etc.: ViiV; Johnson & Johnson; Gilead (Relationship Ended)
 
				- Consulting Fee (All Relationships Ended): Gilead; Merck; Moderna 
 
				- Grant or Research Support: Pfizer;  Gilead; Johnson & Johnson (Relationship Ended); Sanofi Genzyme (Relationship Ended); Moderna (Relationship Ended)
 
			 
			
			
			Katherine Bar, MD (Program Co-director)
			 
			
				- Consulting Fee: AbbVie, ViiV, Merck (Relationship Ended)
 
			 
			
			
			Karine Dubé, DrPH, MPhil
			 
			
				- Consulting Fee: Gilead 
 
				- Grant or Research Support: Merck
 
				- Advisor: ViiV, AbbVie (Relationship Ended)
 
			 
			 
			
			
			
			
			
			
			
			 
			 | 
		 
	
 
Discussion of Investigational and/or Off-label Use of Commercial Products and Devices 
The Perelman School of Medicine at the University of Pennsylvania requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside DA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.
 
Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.
 
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. 
 
 
 
 
 
 
 
 
 
 
 |